Welcome Wondros Family and
Friends! We are beta testing and need
your help improving this product.
Share Feedback
Locations
1 locations
Status
Completed
Study Type
Interventional
Timeframe
Day of admission to day of discharge, estimated 10 days later
Accepts healthy volunteers
No
Age
18 Years +
Gender
All
Placebo Arm
No
Locations
1 locations
Status
Active, not recruiting
Study Type
Interventional
Timeframe
12 Months
Accepts healthy volunteers
No
Age
18 Years - 75 Years
Gender
All
Placebo Arm
No
Locations
1 locations
Status
Recruiting
Study Type
Interventional
Timeframe
Baseline to 12 Weeks
Accepts healthy volunteers
No
Age
45 Years - 70 Years
Gender
Male
Placebo Arm
Yes
Locations
6 locations
Status
Recruiting
Study Type
Interventional
Timeframe
Baseline up to end of treatment
Accepts healthy volunteers
No
Age
18 Years +
Gender
Male
Placebo Arm
No
Locations
1 locations
Status
Withdrawn
Study Type
Interventional
Timeframe
28 days
Accepts healthy volunteers
No
Age
18 Years +
Gender
All
Placebo Arm
Yes
Locations
44 locations
Status
Active, not recruiting
Study Type
Interventional
Timeframe
Extension period through Week 108
Accepts healthy volunteers
No
Age
12 Years +
Gender
All
Placebo Arm
Yes
Locations
1 locations
Status
Completed
Study Type
Interventional
Timeframe
Through study completion, an average 1 year
Accepts healthy volunteers
No
Age
4 Years - 18 Years
Gender
All
Placebo Arm
Yes
Locations
1 locations
Status
Recruiting
Study Type
Interventional
Timeframe
2 weeks
Accepts healthy volunteers
No
Age
18 Years - 75 Years
Gender
All
Placebo Arm
No
Locations
38 locations
Status
Recruiting
Study Type
Interventional
Timeframe
at every single visit up to 60 months
Accepts healthy volunteers
No
Age
18 Years - 70 Years
Gender
All
Placebo Arm
Yes
Locations
1 locations
Status
Active, not recruiting
Study Type
Interventional
Timeframe
Change from Baseline to End of Study (week 12)
Accepts healthy volunteers
No
Age
18 Years - 85 Years
Gender
All
Placebo Arm
Yes
Rural Home Hospital: Proof of Concept
This study examines the implications of providing hospital-level care in rural homes.
Sponsored by:
Brigham and Women's Hospital
Trial Location:
University of Utah Health, Salt Lake City, Utah 84132, United States
Estimated trial timing:
February 18, 2021 - May 07, 2021
EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial
This is a pragmatic, 24 month, single-center, randomized, open-label, parallel-group trial comparing an obesity-centric approach with a medically-s...
Sponsored by:
The Cleveland Clinic
Trial Location:
Cleveland Clinic, Cleveland, Ohio 44195, United States
Estimated trial timing:
September 01, 2020 - March 01, 2023
Wild Blueberries and Cardiovascular Health in Middle-aged/Older Men and Postmenopausal Women
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. Aging is the primary risk factor for CVD, in large part due...
Sponsored by:
Colorado State University
Trial Location:
Food and Nutrition Clinical Research Laboratory, Fort Collins, Colorado 80523-1571, United States
Estimated trial timing:
January 01, 2020 - December 31, 2023
Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland
This phase IIa trial investigates the biomarker (plasma levels of PSA) of low-dose apalutamide in patients with prostate cancer confined in the pro...
Sponsored by:
National Cancer Institute (NCI)
Trial Location:
UC San Diego Medical Center - Hillcrest, San Diego, California 92103, United States
Estimated trial timing:
June 01, 2021 - August 31, 2024
Outpatient Use of Ivermectin in COVID-19
Covid 19, a novel coronavirus, causes infection that, while mild to moderate in many people, can lead to severe disease in a significant portion. C...
Sponsored by:
Temple University
Trial Location:
Temple University Hospital, Philadelphia, Pennsylvania 19140, United States
Estimated trial timing:
April 01, 2021 - June 30, 2021
Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo
The purpose of this study is to evaluate the duration of response following withdrawal of ruxolitinib cream (Cohort A vehicle group), safety and ma...
Sponsored by:
Incyte Corporation
Trial Location:
Northwestern University, Chicago, Illinois 60611, United States
Estimated trial timing:
September 24, 2020 - November 04, 2022
Probiotics and Antibiotic Associated Diarrhea in Pediatric Complicated Appendicitis
To determine the effectiveness of the use of probiotics in patients with a diagnosis of complicated appendicitis on antibiotic associated diarrhea ...
Sponsored by:
Children's Health
Trial Location:
Children's Health Children's Medical Center, Dallas, Texas 75235, United States
Estimated trial timing:
September 08, 2020 - February 28, 2022
Using Electrical Nerve Stimulation to Control Atrial Fibrillation
The purpose of this study is to examine if sending mild electrical signals just under your skin will improve atrial fibrillation symptoms by contro...
Sponsored by:
Cedars-Sinai Medical Center
Trial Location:
CedarsSinaiMC, Los Angeles, California 90048, United States
Estimated trial timing:
November 24, 2021 - July 01, 2023
A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312)
Phase 3 randomized, double-blind, placebo-controlled, study assessing the efficacy and safety of acalabrutinib plus rituximab,cyclophosphamide, dox...
Sponsored by:
Acerta Pharma BV
Trial Location:
Research Site, Clayton, 3168, Australia
Estimated trial timing:
October 08, 2020 - August 31, 2026
Oral Nutritional Supplement Effect on HDL Function
Evaluate the effects of a proprietary supplement on total HDL, HDL functionality, HDL particle size and HDL particle number (HDL-P)
Sponsored by:
Metagenics, Inc.
Trial Location:
Hypertension Institute, Nashville, Tennessee 37205, United States
Estimated trial timing:
August 18, 2020 - December 30, 2022
Our website uses cookies, as almost all websites do, to help provide you with the best experience we can. You can learn more about all the cookies and the information we collect by reading our Privacy Policy.
